Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.

The inaugural AIM investigator conference focused on mast cell diseases, convening to foster a collaborative network among American and European scientists and clinicians specializing in this field. Highlights from the conference include discussions on the biology of mast cells, the genetic basis of hereditary alpha-tryptasemia, and the diverse manifestations and management of mast cell activation syndromes, allergies, and mastocytosis. The meeting underscored the heterogeneity among mast cell disorders and aimed to enhance cooperation in research efforts across continents to better understand these rare conditions and advance diagnostic and therapeutic options.

Symptoms Pharmacological Treatments Nonpharmacological Treatments Underlying Mechanisms Comorbidities Diagnosis / Diagnostic Criteria Management
Published March 23, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.
Contributors
Source

The Journal of allergy and clinical immunology

Medical Disclaimer

The purpose of this website is to inform and educate only. The information provided here is not intended to serve as professional medical advice, diagnosis, or treatment.

If you have health related issues, please contact a qualified health professional to get the personalized assessment, advice, and treatment that you need.

The creators of this living library, documentary and/or website will not be liable for any direct, indirect, or other damages arising from the use of these resources.